Stephanie Berg

Farewell SF and #GU24! @DrChoueiri (my fearless leader and mentor) sums up the week below. We @DanaFarber_GU will take back the excellent science, data, and advocacy presented to continue to #conquercancer with our patients! @ASCO @DanaFarber @OncoAlert

The future is now. Don’t miss “Tools for Tomorrow’s Oncologist” at #WorldGU25—an essential session featuring Drs. @katy_beckermann, @bergsa83, @EHeath4100, Kelvin Moses, Lisa Raff, PharmD, @drulkav, and Elizabeth Wulff-Burchfield, MD. Aug 21–23 | Nashville, TN | Up to 11.75 CE…

🔔KEYNOTE-B61 longest follow up (3 years!) for papillary, chromophobe , translocation and unclassified RCC. Congrats to @AlbigesL @MVossMD ORR 51% , mPFS 18mo, mOS 42.5 @Merck #KCRS25

A032201/Adjuvant RCC trial now enrolling! @ALLIANCE_org #KCRS25 open @DanaFarber_GU and over 200 sites nationwide! Glad to see it discussed on the main stage cancer.gov/research/parti…

One month left to register for KCA's Women in RCC summer webinar! Join a conversation with @KimrynRathmell @OSUCCC_James - a leading voice in #kidneycancer research and care - about leadership and career development. 📆 August 14, 7-8 pm ET 👉 Sign up bit.ly/3Gf9wgV

⁦@KimrynRathmell⁩ delivering the keynote address at #KCRS25. ⁦@OSUWexMed⁩ ⁦@OSUCCC_James⁩ ⁦@OSU_Urology⁩ ⁦@kidneycan⁩

Only 5 days to go until #KCRS25 kicks off in Boston! From keynote speakers to new trial data and patient-centered conversations, this summit brings the #KidneyCancer community together like no other. #AcceleratingCures

Where kidney cancer science meets collaboration. Pre-register now to attend KCRS 2025 virtually, free of charge for patients, caregivers, researchers, and advocates! 🔗 bit.ly/RegisterKCRS25 #KCRS25 #AcceleratingCures

Are you a testicular cancer patient, survivor, caregiver or tc medical provider? Our 10th annual Testicular Cancer Conference presented by @FennecPharma is soon approaching - register today! Special thanks to @BrighamMass @DanaFarber @Harvard Click link to register today -…

The 4th live Uromigos meeting is happening on 7th & 8th Nov ‘25 in Nashville. It’s going to have an international flavour with America’s 🇺🇸 🇨🇦 vs Eurasia 🇯🇵 🇨🇳 🇮🇳 🇦🇺 🇪🇺 Uromigos Cup competition (details to follow). Sessions ranging from ADCs in MIBC to the changing shape of…

Covering metastatic prostate cancer in 20min done by the one and only @AtishChoudhury Opa! @DanaFarber_GU @PGrivasMDPhD

@PGrivasMDPhD & #Dr.Papatsoris kick off the GU oncology session in this high impact mtg discussing molecular medicine & translation from lab to clinic across cancers. @drjefstathiou @Prof_Nick_James @UrologieParis @bergsa83 @karima_oualla @UroDocAsh #T.Freidlander…

GU Research Digest for the week of June 14 - 20: a selection of publications about GU cancers in high-impact journals. Search the PMIDs on pubmed.ncbi.nlm.nih.gov to read!

Join us in Athens June 26-28 for fantastic oncology meeting with stellar experts! Great for trainees :-) @shilpaonc @Prof_Nick_James @karima_oualla @BourlonMaite @VivekSubbiah @BrainTumorDoc @bergsa83 @WHBA1990 @MichalisLiontos @mtsiatas @AKyriazoglou facebook.com/share/v/1BqHiA…

Thrilled to have Dr. @bergsa83 on the #WorldGU25 faculty! Her expertise in kidney cancer clinical trials and therapy will make this CE-accredited conference unforgettable. Join us Aug 21–23 in Nashville, TN. Register now: hubs.la/Q03rhPpj0 #KidneyCancer #GUoncology…

Thank you to the discussant Rahul Aggarwal and @jordanciuro for highlighting A-DREAM for treatment interruption for pts with PSA < 0.2 after 18-24 mo of ADT+ARPI, with primary endpoint of 18 months treatment-free with testosterone recovery. @DanaFarber_GU @bergsa83 @ALLIANCE_org

HRQoL presented by @CaPsurvivorship @DanaFarber_GU @ASCO #ASCO25 from ARANOTE , patient reported outcomes Daro delayed pain progression and benefits over placebo in overall well being

Great job by Ilana E. presenting ctDNA data from our combined @DanaFarber_GU @MGHCancerCenter @BrighamRadOnc cohort of patients with MIBC treated with TMT! Post-treatment ctDNA status is highly prognostic in the TMT setting.

Congrats to the ATOMIC/A021502 investigators ! @ALLIANCE_org positive DFS and OS for adjuvant dMMr CRC. Years of work and hundreds of patients. @NCICancerTrials @ASCO

Congrats @TiansterZhang and @DrChoueiri @ALLIANCE_org for A031704/PDIGREE step 1 results and the years it took, persistence and trial design with patient support ! Largest RCC trial in the NCTN to date!

Heading to #ASCO25? More than 40 oral abstracts are presented or led by @DanaFarber – Research advances presented in #Breast, #GI, #GU, #Pediatric, #Lung, #HemOnc, #Gynecologic, #CNS, #HealthServices, #HeadNeck, #TumorBiology, #Prevention. List here: bit.ly/4kCXsEL